Paul Glenn, Montecito investor and philanthropist, dies at 89
Paul F. Glenn, a successful commodities trader whose foundation invested more than $100 million into research related to aging and longevity, has died in Montecito at age 89. He was a native of Pennsylvania who attended Princeton and Harvard Law School before embarking on a career as a commodities trader. Much of his success came Read More →
Read More →Resonant reports earnings bump
Resonant, the Goleta-based maker of components for wireless devices, reported a sharp increase in sales and a reduced cash burn for its third quarter ended Sept. 30. The company said revenue jumped to $1.4 million, compared to $79,000 in the same quarter a year ago and $600,000 in the second quarter, as it received a Read More →
Read More →SLO County names interim airports chief
San Luis Obispo County has found a new airports director in its own deputy director. Courtney Johnson, who has been the county’s airports deputy director since January 2019, will serve in an interim role leading the agency after current director Kevin Bumen steps down on Oct. 10 to take a job at San Francisco International Read More →
Read More →Manufacturing Council for Ventura County gains steam
An effort to create an interest group around manufacturing is picking up speed in Ventura County. Haas Automation executive Peter Zierhut told an Econmic Development Collaborative board meeting on Sept. 17 that he’s had expressions of interest from a number of firms, including Meissner Filtration and AeroVironment, to formalize an organization that would look at Read More →
Read More →Arcutis shares up on news of public, private offerings
Arcutis Biotherapeutics saw a 15 percent rise in its share price after it said Sept. 29 that it will offer 4 million shares to the public and sell another $35 million in stock to an affiliate of one of its directors. Arcutis closed at $31.04, a gain of $4.28 after it announced the dual track Read More →
Read More →Cure closes $20M CBD acquisition
Cure Pharmaceutical, an Oxnard cannabis products manufacturer, has completed its $20 million cash-and-stock buyout of the CBD company Sera Labs, a deal Cure says will help it reach positive cash flow in around 18 months. Cure’s stock, which is traded on the over-the-counter markets, fell 3 percent following the announcement, closing at $1.29 per share Read More →
Read More →